Diverse Roles and Characteristics of Academic Research Organizations in Japan: Results of A Questionnaire-Based Study
Background Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established...
Saved in:
Published in | Therapeutic innovation & regulatory science Vol. 59; no. 5; pp. 1098 - 1106 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.09.2025
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 2168-4790 2168-4804 2168-4804 |
DOI | 10.1007/s43441-025-00797-9 |
Cover
Abstract | Background
Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan’s unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan.
Methods
We distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers’ working hours.
Results
Responses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2–80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers’ working hours.
Conclusion
The roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution’s clinical research priorities and principles. |
---|---|
AbstractList | Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan's unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan.
We distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers' working hours.
Responses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2-80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers' working hours.
The roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution's clinical research priorities and principles. BackgroundClinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan’s unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan.MethodsWe distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers’ working hours.ResultsResponses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2–80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers’ working hours.ConclusionThe roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution’s clinical research priorities and principles. Background Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan’s unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan. Methods We distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers’ working hours. Results Responses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2–80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers’ working hours. Conclusion The roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution’s clinical research priorities and principles. Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan's unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan.BACKGROUNDClinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan's unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan.We distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers' working hours.METHODSWe distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers' working hours.Responses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2-80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers' working hours.RESULTSResponses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2-80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers' working hours.The roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution's clinical research priorities and principles.CONCLUSIONThe roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution's clinical research priorities and principles. |
Author | Haze, Tatsuya Ijuin, Akifumi Hara, Koji Goto, Takahisa Nozaki, Akito Miyagi, Etsuko Okada, Kozo Inagaki, Naoko Tanoshima, Reo Tanaka, Riki Yamamoto, Tetsuya Fukuoka, Hironori Kobayashi, Yusuke Nitta, Manabu |
Author_xml | – sequence: 1 givenname: Reo surname: Tanoshima fullname: Tanoshima, Reo email: reotano@yokohama-cu.ac.jp organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Health Data Science, Graduate School of Data Science, Yokohama City University – sequence: 2 givenname: Riki surname: Tanaka fullname: Tanaka, Riki organization: Business Consultant, Yokohama City University Hospital – sequence: 3 givenname: Koji surname: Hara fullname: Hara, Koji organization: Graduate School of Economics and Business Administration, Yokohama City University – sequence: 4 givenname: Hironori surname: Fukuoka fullname: Fukuoka, Hironori organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Gastroenterological Surgery, Yokohama City University – sequence: 5 givenname: Tatsuya surname: Haze fullname: Haze, Tatsuya organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine – sequence: 6 givenname: Naoko surname: Inagaki fullname: Inagaki, Naoko organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 7 givenname: Akifumi surname: Ijuin fullname: Ijuin, Akifumi organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Reproduction Center, Yokohama City University Medical Center – sequence: 8 givenname: Manabu surname: Nitta fullname: Nitta, Manabu organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Cardiology, Yokohama City University Graduate School of Medicine – sequence: 9 givenname: Yusuke surname: Kobayashi fullname: Kobayashi, Yusuke organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital – sequence: 10 givenname: Kozo surname: Okada fullname: Okada, Kozo organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Division of Cardiology, Yokohama City University Medical Center – sequence: 11 givenname: Akito surname: Nozaki fullname: Nozaki, Akito organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Gastroenterological Center, Yokohama City University Medical Center – sequence: 12 givenname: Etsuko surname: Miyagi fullname: Miyagi, Etsuko organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Obstetrics and Gynecology, Yokohama City University Hospital – sequence: 13 givenname: Tetsuya surname: Yamamoto fullname: Yamamoto, Tetsuya organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Neurosurgery, Yokohama City University School of Medicine – sequence: 14 givenname: Takahisa surname: Goto fullname: Goto, Takahisa organization: Department of Anesthesiology and Critical Care Medicine, Yokohama City University Graduate School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40445582$$D View this record in MEDLINE/PubMed |
BookMark | eNp90U1PFTEUBuDGYASRP-DCNHHjZrSfM607vKBiSIio6-bQnoGSuZ1LO0MCv95eBzBxYTdtk-dtm74vyU4aExLymrP3nLHuQ1FSKd4woZu6tV1jn5E9wVvTKMPUzuO6s2yXHJRyzeqwRnfCvCC7iimltRF7ZD6Kt5gL0vNxwEIhBbq6ggx-whzLFH2hY08PPQRcR0_PsSBkf0XP8iWkeA9THFOhMdFvsIH0cQvmYVpC9PuMZQsSxIzNJygY6I9pDnevyPMehoIHD_M--fX5-Ofqa3N69uVkdXjaeCnM1HjNgvctggBvuTFtD32rZfBMm3ChbW-5MuCRqR6DQtV55Bo7oUTQOrQo98m75dxNHm-2j3HrWDwOAyQc5-Kk4EpyZa2o9O0_9Hqcc6qvq0oLbrSUrKo3D2q-WGNwmxzXkO_c44dWIBbg81hKxv6JcOa2xbmlOFeLc3-Kc7aG5BIqFadLzH_v_k_qN99GmrA |
Cites_doi | 10.3389/fmed.2021.816921 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to The Drug Information Association, Inc 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2025. The Author(s), under exclusive licence to The Drug Information Association, Inc. The Author(s), under exclusive licence to The Drug Information Association, Inc 2025. |
Copyright_xml | – notice: The Author(s), under exclusive licence to The Drug Information Association, Inc 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2025. The Author(s), under exclusive licence to The Drug Information Association, Inc. – notice: The Author(s), under exclusive licence to The Drug Information Association, Inc 2025. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7U7 C1K K9. NAPCQ 7X8 |
DOI | 10.1007/s43441-025-00797-9 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2168-4804 |
EndPage | 1106 |
ExternalDocumentID | 40445582 10_1007_s43441_025_00797_9 |
Genre | Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GrantInformation_xml | – fundername: Internal Research Funding of Yokohama City University. |
GroupedDBID | 01A 0R~ 2JY 406 53G 7RV 7X7 88I 8AF 8AO 8FE 8FH 8FI 8FJ 8FW 8G5 AACDK AAHNG AAJBT AARDL AASML AATNV AAUYE ABAKF ABAWP ABBRH ABCCA ABDBE ABECU ABFSG ABFTV ABJNI ABKCH ABMQK ABRTQ ABTEG ABTKH ABUWG ACAOD ACDTI ACDXX ACGFS ACGOD ACHSB ACPRK ACSTC ACZOJ ADBBV ADTPH ADYFF AEFQL AEMSY AENEX AERKM AESKC AEUHG AEWDL AEZWR AFBBN AFDZB AFHIU AFKRA AFOHR AFQWF AFRAH AGMZJ AGQEE AHMBA AHPBZ AHWEU AIGIU AILAN AIXLP AJZVZ ALMA_UNASSIGNED_HOLDINGS AMXSW AMYLF ARTOV ATHPR AUTPY AYAKG AYFIA AZQEC BBNVY BCU BEC BENPR BHPHI BKEYQ BKOMP BPHCQ BVXVI CCPQU DPUIP DWQXO EBLON EBS EJD EX3 FIGPU FNLPD FYUFA GNUQQ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GUQSH H13 HCIFZ HF~ HMCUK HZ~ IKXTQ IWAJR J8X JZLTJ K.F KOV LK8 LLZTM M2O M2P M2Q M7P NAPCQ NPVJJ NQJWS O9- P.B PHGZM PHGZT PPXIY PQGLB PQQKQ PROAC PT4 PUEGO ROL RSV S01 S0X SAUOL SCNPE SFC SJFOW SJYHP SNE SNPRN SOHCF SOJ SRMVM SSLCW UKHRP WOW ZCA AAYXX CITATION CGR CUY CVF ECM EIF NPM --- 29G 5GY 77I 7U7 8R4 8R5 BES C1K E3Z F5P K9. P2P PRG Q2X SJN TAE VQ3 7X8 |
ID | FETCH-LOGICAL-c328t-c50dcc6ea2ac91886faf653dc058db59f9148ace04fed4e47ce15e7242d55d6e3 |
ISSN | 2168-4790 2168-4804 |
IngestDate | Fri Sep 05 15:57:37 EDT 2025 Thu Sep 25 00:55:49 EDT 2025 Sat Sep 20 02:12:52 EDT 2025 Thu Sep 25 00:50:45 EDT 2025 Fri Sep 19 01:10:31 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Questionnaire survey Academic research organization Work style reforms Financial independence Mission |
Language | English |
License | 2025. The Author(s), under exclusive licence to The Drug Information Association, Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c328t-c50dcc6ea2ac91886faf653dc058db59f9148ace04fed4e47ce15e7242d55d6e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 40445582 |
PQID | 3252185330 |
PQPubID | 30058 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_3214314992 proquest_journals_3252185330 pubmed_primary_40445582 crossref_primary_10_1007_s43441_025_00797_9 springer_journals_10_1007_s43441_025_00797_9 |
PublicationCentury | 2000 |
PublicationDate | 20250900 |
PublicationDateYYYYMMDD | 2025-09-01 |
PublicationDate_xml | – month: 9 year: 2025 text: 20250900 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Switzerland – name: Thousand Oaks |
PublicationTitle | Therapeutic innovation & regulatory science |
PublicationTitleAbbrev | Ther Innov Regul Sci |
PublicationTitleAlternate | Ther Innov Regul Sci |
PublicationYear | 2025 |
Publisher | Springer International Publishing Springer Nature B.V |
Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
References | 797_CR7 797_CR8 S Saeki (797_CR10) 2024; 7 797_CR5 797_CR6 H Maeda (797_CR2) 2022; 8 797_CR3 797_CR4 797_CR1 797_CR9 |
References_xml | – ident: 797_CR4 – ident: 797_CR3 – volume: 8 year: 2022 ident: 797_CR2 publication-title: Front Med (Lausanne) doi: 10.3389/fmed.2021.816921 – ident: 797_CR5 – ident: 797_CR6 – ident: 797_CR1 – volume: 7 start-page: 457 issue: 3 year: 2024 ident: 797_CR10 publication-title: JMAJ – ident: 797_CR9 – ident: 797_CR8 – ident: 797_CR7 |
SSID | ssj0000985728 |
Score | 2.3237975 |
Snippet | Background
Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical... Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for... BackgroundClinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1098 |
SubjectTerms | Biological research Biomedical Research - organization & administration Clinical trials Clinical Trials as Topic Drug Safety and Pharmacovigilance Hospitals Humans Japan Medical research Medicine Organizations Pharmacotherapy Pharmacy Questionnaires Research centers Research Personnel Surveys Surveys and Questionnaires Working hours |
Title | Diverse Roles and Characteristics of Academic Research Organizations in Japan: Results of A Questionnaire-Based Study |
URI | https://link.springer.com/article/10.1007/s43441-025-00797-9 https://www.ncbi.nlm.nih.gov/pubmed/40445582 https://www.proquest.com/docview/3252185330 https://www.proquest.com/docview/3214314992 |
Volume | 59 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJyFeEIxbYSAjob20QWliJzFv7aCaJm2aUCftLXJsRwuFZGqbh_E3-UOc2M6ll0mMl6hyThy35-vx8bki9CkcS0Y5o46s6l8SJnyHiYQ7UlJQH6SbhryyQ55fBKdX5OyaXvd6fzpRS-U6-Sx-780r-R-uwhjwtcqSfQBnm0lhAD4Df-EKHIbrP_H4qw6qUMPvVVUm7QY42aq_XOmZdQR8HWS3mX9ZGTzOYMfMTWjcqvxpojsmQ20LBZKcg1h0prDdSR12uOEInrf5WzBT3WFVA2pp2txXTny7z7ZmgrxY3WS_rOJadMb5wgxmi6wVjkuTt1b8aMZm5aIsDOlplahXLLOu_cKjTYDWpv1yywLaGuFageiNA20JNH4c1RmLTAvjWqLbGuNZ12d-azrsmpbXdqsH1SfYu42YyJEV8UFZdPSa3ZCFDms3zSaUsSn7rIljII41ccweoQMvBIWujw4ms-n0ojH9wSJoqLv-Nt_IpnPppM6dt26qTDvnoB0fvlaN5s_QU3umwRMD0Oeop_JD9PjcRm0couNLUx_9boQ7cFmN8DG-bCun371ApQU01oDGAGi8BWhcpLgGNK4BjTcAjbMca0B_wRbO-iG8B85Yw_klupp9m5-cOrYviCN8L1o7grpSiEBxjws2jqIg5WlAfSlcGsmEspTBGZ8L5ZJUSaJIKNSYqhCUURBAMlD-K9TPi1y9QZhLwXhCBFHKJzRRDB4XzE2oy5mi43SAhvVPH9-a8i_x_RwfoKOaO7EVE6vY90BDjqog7gH62NwGIV555niuirKigWPLmDDmDdBrw9XmdcQlhNII7oxqNreT37-Wtw8jf4eetH_OI9RfL0v1HtTtdfLBwvcvcnnVFg |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diverse+Roles+and+Characteristics+of+Academic+Research+Organizations+in+Japan%3A+Results+of+A+Questionnaire-Based+Study&rft.jtitle=Therapeutic+innovation+%26+regulatory+science&rft.au=Tanoshima%2C+Reo&rft.au=Tanaka%2C+Riki&rft.au=Hara%2C+Koji&rft.au=Fukuoka%2C+Hironori&rft.date=2025-09-01&rft.pub=Springer+International+Publishing&rft.issn=2168-4790&rft.eissn=2168-4804&rft.volume=59&rft.issue=5&rft.spage=1098&rft.epage=1106&rft_id=info:doi/10.1007%2Fs43441-025-00797-9&rft.externalDocID=10_1007_s43441_025_00797_9 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-4790&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-4790&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-4790&client=summon |